These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 160)

  • 61. Clinical pharmacokinetics of procainamide.
    Karlsson E
    Clin Pharmacokinet; 1978; 3(2):97-107. PubMed ID: 346289
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antiarrhythmic efficacy of N-acetylprocainamide in patients with premature ventricular contractions.
    Lee WK; Strong JM; Kehoe RF; Dutcher JS; Atkinson AJ
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):508-14. PubMed ID: 776488
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.
    Drayer D; Kluger J; Reidenberg M; Lahita R
    Drug Metab Rev; 1979; 10(2):239-46. PubMed ID: 95247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B; Jadot G
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias.
    Kluger J; Drayer D; Reidenberg M; Ellis G; Lloyd V; Tyberg T; Hayes J
    Am J Cardiol; 1980 Jun; 45(6):1250-7. PubMed ID: 6155064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM; Drayer DE
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Simultaneous determination of procainamide and N-acetylprocainamide in plasma by high-performance liquid chromatography.
    Butterfield AG; Cooper JK; Midha KK
    J Pharm Sci; 1978 Jun; 67(6):839-42. PubMed ID: 660471
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hemodynamic effects of n-acetylprocainamide compared with procainamide in conscious dogs.
    Badke FR; Walsh RA; Crawford MH; Ludden T; O'Rourke RA
    Circulation; 1981 Dec; 64(6):1142-50. PubMed ID: 6170473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
    Richardson B; Cornacchia E; Golbus J; Maybaum J; Strahler J; Hanash S
    Arthritis Rheum; 1988 Aug; 31(8):995-9. PubMed ID: 2457378
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved semi-automated analysis of procainamide and N-acetyl procainamide utilizing a totally volatile mobile phase.
    Quattrone AJ; Putnam RS
    J Anal Toxicol; 1981; 5(2):101-4. PubMed ID: 6165861
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microdetermination of procainamide in human serum.
    Ludden TM; Lalka D; Wyman MG; Goldreyer BN; Haegele KD; Brooks DT; Davila I; Wallace JE
    J Pharm Sci; 1978 Mar; 67(3):371-3. PubMed ID: 641726
    [TBL] [Abstract][Full Text] [Related]  

  • 74. N-Acetylprocainamide levels in patients with end-stage renal failure.
    Gibson TP; Matusik EJ; Briggs WA
    Clin Pharmacol Ther; 1976 Feb; 19(2):206-12. PubMed ID: 1261157
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
    Wu KM; Hoffman BF
    Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Direct determination of procainamide and N-acetylprocainamide by capillary zone electrophoresis in pharmaceutical formulations and urine.
    Vargas G; Havel J; Hadasová E
    J Chromatogr A; 1997 Jun; 772(1-2):271-6. PubMed ID: 9226929
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
    Lam YW; Watkins CE
    Clin Pharm; 1993 Jan; 12(1):49-52. PubMed ID: 7679064
    [No Abstract]   [Full Text] [Related]  

  • 78. Production and characterization of specific antibody for radioimmunoassay of procainamide.
    Mojaverian P; Chase GD
    J Pharm Sci; 1980 Jun; 69(6):721-4. PubMed ID: 7205592
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Remission of procainamide-induced lupus erythematosus with N-acetylprocainamide therapy.
    Stec GP; Lertora JJ; Atkinson AJ; Nevin MJ; Kushner W; Jones C; Schmid FR; Askenazi J
    Ann Intern Med; 1979 May; 90(5):799-801. PubMed ID: 312047
    [No Abstract]   [Full Text] [Related]  

  • 80. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.